These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21664687)

  • 1. Vaccine discovery and translation of new vaccine technology.
    Rappuoli R; Black S; Lambert PH
    Lancet; 2011 Jul; 378(9788):360-8. PubMed ID: 21664687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and benefits of immunizing pregnant women: the risk of doing nothing.
    Brent RL
    Reprod Toxicol; 2006 May; 21(4):383-9. PubMed ID: 16290279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing vaccinations: why are so many Americans opting out of vaccinating their children?
    Calandrillo SP
    Univ Mich J Law Reform; 2004; 37(2):353-440. PubMed ID: 15568260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A crisis of public confidence in vaccines.
    Black S; Rappuoli R
    Sci Transl Med; 2010 Dec; 2(61):61mr1. PubMed ID: 21148125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the research-based industry approaches vaccine development and establishes priorities.
    André FE
    Dev Biol (Basel); 2002; 110():25-9. PubMed ID: 12477303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination perspectives].
    Saliou P; Plotkin S
    Sante; 1994; 4(3):237-41. PubMed ID: 7921696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.
    Levine MM; Levine OS
    Lancet; 1997 Nov; 350(9088):1386-92. PubMed ID: 9365466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines.
    Larson HJ; Smith DM; Paterson P; Cumming M; Eckersberger E; Freifeld CC; Ghinai I; Jarrett C; Paushter L; Brownstein JS; Madoff LC
    Lancet Infect Dis; 2013 Jul; 13(7):606-13. PubMed ID: 23676442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating vaccine safety during the development and introduction of vaccines.
    Kochhar S
    Curr Drug Saf; 2015; 10(1):55-9. PubMed ID: 25859676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-preventable diseases: from paediatric to adult targets.
    Esposito S; Durando P; Bosis S; Ansaldi F; Tagliabue C; Icardi G;
    Eur J Intern Med; 2014 Mar; 25(3):203-12. PubMed ID: 24389370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.
    Ortiz JR; Neuzil KM; Ahonkhai VI; Gellin BG; Salisbury DM; Read JS; Adegbola RA; Abramson JS
    Vaccine; 2012 Nov; 30(50):7134-40. PubMed ID: 23026690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine research, development, and innovation in Brazil: a translational science perspective.
    Homma A; Tanuri A; Duarte AJ; Marques E; de Almeida A; Martins R; Silva-Junior JB; Possas C
    Vaccine; 2013 Apr; 31 Suppl 2():B54-60. PubMed ID: 23598493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.